Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Bayer Schering Partners with NPERC on Drug Delivery

publication date: Nov 9, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Bayer Schering Pharma (XETRA: SCH) signed an agreement to conduct joint research on a biodegradable injection drug delivery system with the National Pharmaceutical Engineering Research Center. NPERC is a subsidiary of the Shanghai Institute of Pharmaceutical Industry (SIPI). Financial terms were not disclosed. More details....

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...